# FDA Inspection 1286816 - Dendreon Pharmaceuticals LLC - October 29, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/7b3579a1-1d37-40bc-8b3f-16301d44a749
Source feed: FDA_Inspections

> FDA Inspection 1286816 for Dendreon Pharmaceuticals LLC on October 29, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286816
- Company Name: Dendreon Pharmaceuticals LLC
- Inspection Date: 2025-10-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Atlanta District Office

## Related Documents

- [FDA Inspection 1169722 - 2022-04-21](https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/93960652-a112-4468-ab29-2dcdbc9fb9a2)
- [FDA Inspection 1070321 - 2018-10-22](https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/e8e5b54b-3f67-4a9a-85a5-849f625ada54)
- [FDA Inspection 1031496 - 2016-11-01](https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/2023ed60-8b86-4221-9226-16ab7b43659f)

Company: https://www.globalkeysolutions.net/companies/dendreon-pharmaceuticals-llc/3de4a8e5-8e34-4212-8862-ecd5256c6ffe

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7